ANGIODYNAMICS INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q4 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Angiodynamics Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q4 2020 to Q2 2024.
- Angiodynamics Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending May 31, 2024 was -$14.1M, a 35.3% increase year-over-year.
- Angiodynamics Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending May 31, 2024 was -$192M, a 252% decline year-over-year.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$192M, a 252% decline from 2022.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$54.4M, a 81.8% decline from 2021.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$29.9M, a 16.9% increase from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)